Le Lézard
Classified in: Health
Subjects: POLITICS, HEALTH

REPEAT: Media Availability: The Ford Government is Doing Substantially Nothing to Address the Hospital Crisis


Attn: Assignment Editor

TORONTO, Dec. 12, 2022 (GLOBE NEWSWIRE) --

What:
Ontario Health Coalition leader Natalie Mehra will be available to respond to the Ford government's denial and downplaying of the hospital crisis and failure to address it outside the Queen's Park south facing main entrance on Monday December 12 at 10 am along with patients, leaders of community organizations and health care professionals.

The Ontario Health Coalition is holding protests and marches outside hospitals in major cities across Ontario on Monday at noon. There are events at the following locations:

For more information: Natalie Mehra, Executive Director (416) 230-6402 (cell); Salah Shadir, Administration & Operations Manager (647) 648-5706 (cell)



These press releases may also interest you

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...



News published on and distributed by: